JellyFil Official Website › Disclaimer
DisclaimerJellyFil Disclaimer: the Limits on Everything Written Here
JellyFil is a dietary supplement, not a drug, and it is not FDA-approved. These statements have not been evaluated by the Food and Drug Administration and the product is not intended to diagnose, treat, cure or prevent any disease. Individual results vary, and no page here is medical advice.
The FDA statement, the medical limit, the results limit, the blend limit and the reference limit, each stated once and in full.
The FDA statement on the JellyFil bottle and on this website
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
The FDA does not approve dietary supplements before they are sold. That is not a loophole, it is how the category works, and it means no supplement anywhere can honestly be described as FDA-approved.
The bottle carries an FDA-registered-facility mark. Registration is a filing about the factory. It is not review and it is not approval, and the testing and quality page takes that mark apart in detail.
The medical limit on JellyFil content
Nothing on this website is medical advice and nothing here is a substitute for a clinician who can examine you.
Two situations deserve naming rather than a general caution. If you take a nitrate, a blood-pressure medicine or an erectile-dysfunction prescription, the plant to raise is horny goat weed, because its isolated compound inhibits the same enzyme. If you have liver trouble or take something already hard on the liver, the plants to raise are green tea extract and ashwagandha, both of which carry published liver signals.
And if erectile difficulty is new, arrived quickly, or is worsening month by month, the cardiology consensus treats it as a cardiovascular marker worth investigating. That is an appointment rather than a purchase.
The results limit on JellyFil
Individual results vary, and on this product the variation is larger than usual because the outcomes it is sold for are shaped by sleep, alcohol, bodyweight, blood pressure and activity as much as by anything in a bottle.
Buyers on this desk describe 3-4 weeks before anything is worth judging. That is a reported pattern rather than a prediction, and no page here promises a timeline.
Review scores, star distributions and order counts on this website are the distributor's own summary figures. This desk did not collect them and cannot audit them, and the reviews page says so at length.
The blend limit on the JellyFil panel
The panel prints one figure for the whole blend: 82 mg across 9 plants, footnoted as roughly 567 mg of dry-powder equivalent. Only caffeine, at 5 mg, has a figure of its own.
That format is permitted under 21 CFR 101.36 and it is ordinary. What follows from it is that no per-plant amount on this website is attributed to the gummy, because none exists to attribute. Every dose quoted anywhere here is the dose a published trial gave people, and it is labelled as such wherever it appears.
No page on this website estimates what share of the blend any plant represents. An estimate would be a guess wearing a number, and a guess wearing a number is the single most misleading thing a page like this can print.
The reference limit behind the JellyFil pages
Every citation on this website was confirmed through its NCBI record in the session that wrote it: authors, title, journal, year, volume, issue and pages read back rather than recalled, with doses read out of the abstracts.
A retraction sweep was run twice: once against each record's publication type, and once against its correction graph. No record in the set is retracted. One carries a published erratum and is cited with that stated.
What a citation is not is evidence about this gummy. Every trial cited here studied a plant, at a stated dose, usually on its own. The category audit found no finished men's formula with a published trial of its own, and this bottle is not an exception.
The commercial disclosure on the JellyFil website
Jellyfile sells this product and earns from orders placed through the checkout this website links to. That is the conflict of interest, it is structural, and it is disclosed on every page rather than in a footnote.
The editorial rules that exist because of it are on the about page, together with the three sentences from the seller's own marketing that this desk has refused to reproduce.
The precautions printed with every JellyFil bottle
- Dietary supplement. Not a drug, and not FDA-approved.
- Chewable gummy. Not a capsule and not liquid drops.
- For healthy adults aged 18 and over. Not for anyone under 18.
- Talk to a doctor before use if you take any medicine.
- Do not take more than the label says unless a clinician tells you to.
- Individual results vary. Food, sleep and activity still matter.
- Lot JEL-26/JE-5655 and certificate reference JEL-5655-26-JE are filing references, not laboratory proof.
- The website email cannot see orders. For a refund, call +1 (507) 448-8190.
- The money-back guarantee is a purchase policy, not a medical promise.
- This website is a retailer, not the manufacturer.
Where to read further about JellyFil
Read the JellyFil label on the bottle you receive
Everything on this website is written from it, and the bottle in your hand is the authority if the two ever disagree.
From $158 for two bottles to $294 for six, with 60 days on all three
Choose A JellyFil PackChewed, one a day, 30 to a bottle. Batch JEL-26/JE-5655, shipped from the United States.
